Exercise and breast cancer
- Medical Review: Sami Mansfield, ACSM-CET, PN1
Getting regular exercise is important for everyone — and it’s especially critical for people diagnosed with breast cancer. Research shows that meeting minimum weekly exercise requirements as recommended by Physical Activity Guidelines for Americans can significantly reduce the risk of a breast cancer recurrence and the risk of death from any cause.
Exercise is physical activity that is structured and repetitive. And it doesn’t just help reduce the risk of recurrence and improve survival after a diagnosis. Exercise also helps reduce treatment-related side effects including joint pain, fatigue, chemobrain, depression, and anxiety.
Below, we’ll talk more about the specific benefits of exercise and provide guidance on how to get started, weekly exercise recommendations, and ways to find an experienced trainer.
We’ll also share LBBC's BeACTive video series, a three-week workout plan hosted by certified cancer exercise trainer Sami Mansfield, founder of Cancer Wellness for Life and co-author of Exercise, diet, and weight management during cancer treatment: American Society of Clinical Oncology (ASCO) guideline. The BeACTive series is tailored for individuals diagnosed with breast cancer and includes exercises for people just starting out or who are feeling limited by energy level and side effects.
Getting started
The American College of Sports Medicine (ACSM) and the American Cancer Society (ACS) recommend exercising during and after cancer treatment. But even with all the benefits — such as reduced risk of recurrence and improved survival — you may not be sure when you should start exercising, or how. It’s normal to feel uncertain about starting or restarting an exercise routine if you’re in treatment, regaining mobility after surgery, recovering from systemic treatment, or living with metastatic disease.
Unless you are dealing with acute problems, such as an active infection or an elevated heart rate, it is safe to exercise. No matter what your age or stage, you can find exercises that meet your abilities and allow you to stay active and build strength.
The biggest tip I would tell people is start slowly, and focus on consistency over duration.
Tips for starting or restarting an exercise routine
When you begin an exercise routine, you may get tired more quickly than you are used to, and it may take longer to recover if you wear yourself out. Even if you have only exercised for a few minutes, building on that through a regular routine will be more helpful than wearing yourself out and taking days to recover.
As you get started, it’s OK to challenge yourself a bit. Aim for some discomfort such as burning in your muscles or feeling out of breath. But watch for things like sharp pain, pain that doesn’t go away after a rest, or lightheadedness or dizziness, which may be signs that you are going too fast and need to slow down your tempo.
It’s very common that your body feels different during and after treatment, especially related to energy or endurance. You may find that it’s more difficult to figure out how long or challenging your exercise sessions should be, and once you get to the point of exhaustion, your recovery is likely to be slower than before cancer. Slow down or stop when you start to feel fatigue that’s beyond muscle tiredness. Try resting for a minute or two, and if you don’t feel ready to start again, give yourself some encouragement for accomplishing your exercise and resuming the next day or the day after that. It’s important to know that while exercise should make you tired, it should not make you too exhausted to continue your day.
You can always add to your routine as you get more comfortable with managing your energy.
LBBC's BeACTive video series
To help you get started on an exercise plan that supports both improved survival and increased qualify of life after a diagnosis of breast cancer, LBBC developed BeACTive: Empowering workouts for people with breast cancer.
BeACTive is a three-week exercise series customized to fit all levels of function and energy. This program is designed to help you reach the evidence-based recommendations for people diagnosed with breast cancer. Minimal equipment is needed, and many of the exercises only require yourself and a chair.
While these recommendations are useful to understand, keep in mind that any exercise has benefits to you not only physically but mentally, so just getting started on a regular regimen of any amount will make a difference!
Watch the video above for a brief introduction to the series. You can explore the full series through the YouTube playlist, or click on a video title below to start where you wish.
Week 1
Week 2
Week 3
Recommendations for people with early-stage breast cancer
Exercise has been found to be safe and beneficial for people undergoing active treatment such as chemotherapy and radiation therapy for early-stage breast cancer.
Though not everyone will have the same access to equipment, space, and guidance, there are many ways to get exercise, even at home.
How much exercise should I get?
Many exercise recommendations — including those from ASCO, ACSM, and ACS — are based on the Physical Activity Guidelines for Americans, released by the Department of Health and Human Services. These suggest that each week, adults, including those in treatment, get:
- At least 150 minutes of moderate-intensity physical activity, or
- At least 75 minutes of vigorous activity
These recommendations include regular aerobic exercise (“cardio”), along with at least two days per week of exercises to build muscle (resistance or strength training).
Understanding exercise intensity
The intensity of exercise depends on how fast your heart is beating and how quickly you’re breathing during the exercise. Using the “talk test” is an informal way to understand general intensity level:
- With moderate-intensity exercise, you can talk, but not sing.
- With vigorous intensity, saying more than a few words is difficult without stopping to breathe.
You can try the talk test with any kind of exercise — such as walking, yoga, or resistance training — to understand its intensity level. A professional cancer exercise trainer can help you figure out your personal target heart rate during exercise. At the end of this page, you can learn more about finding a qualified trainer.
If you have reduced range of motion in your arm after breast cancer surgery, consider asking for a referral to see a physical or occupational therapist.
What is aerobic exercise?
Aerobic exercise is repetitive and uses large groups of muscles, increasing your heart rate and breathing. Aerobic exercise is often referred to as cardiovascular exercise (or simply cardio) because it helps the cardiovascular system, which includes your heart and blood vessels.
Aerobic exercise can help to reduce side effects such as fatigue, nausea, sleep disturbances, depression, and anxiety.
Examples include:
- Walking
- Running
- Exercising with cardio equipment such as a treadmill, stair climber, rowing machine, or elliptical
- Swimming
- Cycling
- Seated aerobics
What is resistance exercise?
Resistance exercise, also called strength training, consists of movements that create muscle overload, which stimulates your body to build new muscular tissue. Resistance exercise can also help:
- Reduce body fat
- Achieve or maintain a healthy body composition: the balance of muscle and fat in your body
Resistance exercise is associated with relief from several side effects, including joint pain, fatigue, and lymphedema*, a painful swelling condition that can develop in some people after lymph node removal surgery.
Examples include:
- Countertop push-ups
- Chest presses
- Core movements such as planks (any version, such as countertop, elevated, or on the floor)
- Lunges (stationary or adding movement forward or back)
- Squats
- Chair sit-to-stand
- Overhead press
- Bicep curls
*If you have had lymph node removal surgery (sentinel node biopsy or axillary lymph node dissection), read our Exercise and lymphedema information below.
Building up to recommended exercise levels
If you are starting a new treatment regimen or are recovering from surgery, it may take time to build up to the recommended exercise levels. That is OK, and you shouldn’t feel discouraged if you are unable to meet those recommendations.
“There may be times when you don’t feel great,” says Mansfield. “Treatment and energy cycles can have an impact.” If you’re having difficulty, let your healthcare team or cancer exercise trainer know.
Ways to reduce inactivity and increase activity
Regular, structured exercise is an important way to get the recommended amount of activity and to include activities that can help manage specific side effects. But remember that exercise isn’t the only way you can get physical activity. Other activities including brisk walks, gardening, dancing, playing with children, and doing chores can all contribute to your overall activity level.
ACSM and ACS recommend adults diagnosed with cancer limit sedentary behaviors such as sitting and lying down for prolonged periods. You can include both structured exercise time and other activities as you work to increase your physical activity.
If you find that you’ve been sitting or lying down for a while — especially for periods over two hours — try taking a short walk, doing some chores, working in a short exercise or stretching routine, or finding another activity to get you moving.
While it’s ideal to move from sitting to standing to get in some activity, seated marching or stretching, or even lying in bed doing leg lifts or hip bridges, can help.
Exercise and lymphedema
When a diagnosis requires that lymph nodes be removed from under the arm, it’s important to know the risk factors for lymphedema, a painful swelling condition that can happen in some people after lymph node surgery. After this surgery, someone on your surgical team will show you exercises that can help recover arm mobility.
It can also help to get familiar with how your post-surgery arm is responding to different types of movement, including exercise. Mansfield recommends starting low and going slow.
ACSM and ACS guidelines note that resistance exercise does not increase the risk of breast cancer-related lymphedema and has been found to help with its symptoms. In fact, according to ACSM and ACS, resistance training twice a week has been found to help manage lymphedema.
Still, there are reasons to ask your healthcare team for a referral to see a lymphedema specialist as you start an exercise program:
- If you are concerned about your risk for lymphedema and want a risk assessment
- If pain and/or swelling develops in the arm or hand
If lymphedema develops, resistance exercises under the guidance of a lymphedema specialist can help reduce symptoms.
Visit our Lymphedema page to learn more.
Exercise and metastatic breast cancer
Metastatic breast cancer (MBC) is breast cancer that has spread to other parts of the body, such as the lung, liver, bones, or brain. Research shows an association between moderate- and vigorous-intensity exercise and improved survival for people with MBC. Exercise can also help reduce MBC-related fatigue and pain.
If you’ve been diagnosed with MBC, there are many safe ways you can exercise. Learn more in Exercise and metastatic breast cancer.
Benefits of exercise
There are multiple strategies for getting physical activity, but planned, purposeful activity through exercise is linked to reduced risk of breast cancer, reduced risk of breast cancer recurrence, and greater survival. Exercise can also help reduce some treatment side effects. In this section, we’ll share specific ways that exercise can be helpful.
Exercise can reduce the risk of breast cancer and recurrence
Fear of recurrence is a common motivation for people to make lifestyle changes, including getting more exercise. ACSM and ACS recommend at least 150 minutes of moderate-intensity exercise or 75 minutes of vigorous exercise each week to reduce the risk of breast cancer, reduce the risk of recurrence, and improve survival.
Women who get the recommended amount of exercise after breast cancer treatment have been found to have lower risk of recurrence and mortality than those who don’t meet those guidelines.
Maintaining a healthy weight is an important part of this risk reduction. After menopause, being overweight or obese raises the risk of breast cancer, because having extra fat tissue can increase estrogen levels, which can help some breast cancers to grow. Being overweight also raises insulin in the blood, which has been linked to breast cancer.
The good news is that following the ACSM and ACS recommendations can reduce body fat, help you maintain a healthy weight, and improve survival.
Exercise can reduce treatment side effects
ASCO guidelines authors found that a combination of regular aerobic and resistance exercise can help manage side effects in people receiving early-stage breast cancer treatment. Benefits include:
- Reduced fatigue
- Increased energy during physical activity
- Improved physical function
- Improved quality of life
- Reduced depression and anxiety
- Improved sleep
- Improved thinking, memory, and focus
- Improved upper- or lower-body strength
Exercise has also been found to help reduce joint pain for people taking aromatase inhibitors.
Exercise can improve cardiovascular health
Cardiovascular health is the health of the heart and blood vessels. Maintaining cardiovascular health reduces the risk of cardiovascular disease — also called heart disease — which refers to any of several conditions including coronary heart disease, arrhythmia, stroke, and heart failure.
Many aspects of cardiovascular disease are related to atherosclerosis, the buildup of plaque in the walls of the arteries, which causes them to narrow. When arteries are narrowed, the flow of blood can become blocked if a blood clot forms, potentially leading to heart attack or stroke.
LDL cholesterol and high blood pressure increase the risk of cardiovascular disease:
- LDL (“bad”) cholesterol is one of the components in the plaque that can form in the artery walls, increasing the risk of heart attack and stroke.
- High blood pressure also increases the risk of heart attack and stroke.
Extra body fat, especially in the abdomen, also increases the risk of cardiovascular disease.
Still, there’s a lot you can do to lower these risks. Following the ACSM and ACS weekly exercise recommendations can help:
- Lower LDL cholesterol
- Raise HDL (“good” cholesterol that helps rid your body of LDL)
- Reduce high blood pressure
- Reduce abdominal fat
Exercise can reduce the risk of breast cancer treatment-related heart failure
Separate from increased risk of heart disease linked to being overweight and obese, breast cancer treatments such as anthracycline chemotherapy, some anti-HER2 treatments, and left-sided radiation therapy can increase the risk of heart damage that can lead to heart failure in some people.
In heart failure (also called congestive heart failure), the heart can’t pump blood as well as it should.
Studies have found that risk factors for cardiovascular disease, such as smoking, obesity, high blood pressure, and high LDL cholesterol, can increase the risk of heart failure linked to these breast cancer treatments. Following the ACSM and ACS recommendations for weekly exercise can lower this risk. Visit Heart health to learn more.
How to find a qualified exercise trainer
While it is not always necessary to have supervised exercise if you have been diagnosed with breast cancer, there are many benefits to working with someone who has specialized training in understanding cancer and treatment side effects.
If you are having cancer-related side effects such as neuropathy or lymphedema, or are undergoing treatment for metastatic breast cancer, it is recommended to start with supervised exercise to address any functional changes and to find a safe and effective starting point.
There are two main groups in the US that certify cancer exercise trainers: The American College of Sports Medicine (ACSM) and the Cancer Exercise Training Institute (CETI). You can visit their websites to look for trainers in your area:
Questions to ask a potential trainer
If you can’t find a certified cancer and exercise trainer near you, there are questions you can ask to see if a trainer may still be a good fit. You can also ask these questions of a certified cancer exercise trainer. Here are some ideas:
- Do you have cancer-specific training and experience?
- Have you worked with someone who has the same diagnosis I do?
- Have you worked with people who are recovering from a major illness?
- Have you worked with people who’ve experienced the side effects I’m experiencing? (examples: fatigue, joint pain, lymphedema, neuropathy, hand-foot syndrome) If so, can you share how you’ve approached training in these situations?
- Have you worked with people as they're recovering from surgery? If yes, how long have you been doing this kind of work? What is your approach?
As you begin working with a trainer, says Mansfield, there should be a balance of feeling that the trainer is pushing your fitness and functional goals while also considering who you are and what you’ve experienced physically.
Moving through cancer downloadable guide
Moving through cancer: A guide to getting and staying active during cancer treatment, published by ACSM, is an additional resource that provides support and information as you start an exercise program. At the links below, you can download English and Spanish versions of this guide.
Related news
- Plant-based diet leads to weight loss—and potential reduced risk of recurrence | ASCO 2024
- 5 surprising benefits of exercise during endocrine treatments
- Exercise improves quality of life in people with metastatic breast cancer | SABCS 2023
- Preparing for breast cancer radiation therapy on the left side with Karen Winkfield, MD, PhD
Related videos
View allStay connected
Sign up to receive emotional support, medical insight, personal stories, and more, delivered to your inbox weekly.
The BeACTive video series was supported in part by the Grant or Cooperative Agreement Number 1 NU58DP006672, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.
Thank you to our in-kind partners
- 3-dimensional radiation therapy
- 4-hydroxytamoxifen
- ablation
- abnormal
- Abraxane
- absolute risk
- AC regimen
- AC-T regimen
- AC-T-T regimen
- AC-Taxol regimen
- AC-TH regimen
- accelerated partial-breast irradiation
- action study
- acupoint
- acupressure
- acupuncture
- acupuncture needle
- acupuncture point
- acupuncture point injection
- acupuncturist
- acustimulation
- acute
- acute pain
- adenocarcinoma
- adenopathy
- adenosis
- adjunct agent
- adjunct therapy
- adjunctive therapy
- adjuvant therapy
- advance directive
- advanced practice nurse
- adverse effect
- aerobic exercise
- agent study
- aggravating factor
- aggressive
- AJCC staging system
- Alkeran
- alkylating agent
- Allegra
- allopathic medicine
- alopecia
- amifostine
- aminoglutethimide
- amitriptyline
- anabolic steroid
- analgesic
- anaplastic
- anastrozole
- ancillary test
- anemia
- anesthesia
- anesthesiologist
- angiogenesis
- angiogenesis inhibitor
- antagonist
- anthracycline
- anti-anxiety medicine
- anti-idiotype vaccine
- anti-inflammatory
- antibody-dependent cellular cytotoxicity
- antibody therapy
- anticachexia
- anticancer antibiotic
- anticancer therapy
- anticonvulsant
- antidepressant
- antiemetic
- antiestrogen
- antifolate
- antigen-presenting cell vaccine
- antihormone therapy
- antimetabolite
- antimitotic agent
- antineoplastic
- antitumor
- anxiety
- anxiolytic
- Anzemet
- APN
- apocrine gland
- apoptosis
- aprepitant
- areola
- Aromasin
- aromatase inhibitor
- aromatherapy
- arthralgia
- ascites
- aspirate
- aspiration
- assay
- asthenia
- asymptomatic
- atypia
- atypical ductal hyperplasia
- atypical hyperplasia
- atypical lobular hyperplasia
- avoidance
- axillary lymph node
- axillary lymph node dissection
- BAK gel
- balloon catheter radiation
- baseline
- behavior modification
- best practice
- BI-RADS
- Biafine cream
- bias
- bilateral
- bilateral breast cancer
- bilateral prophylactic mastectomy
- bilateral salpingo-oophorectomy
- biofeedback
- biologic
- biopsy
- biopsy specimen
- biotherapy
- bisphosphonate
- bisphosphonate-associated osteonecrosis
- blinded study
- blood-brain barrier
- blood-brain barrier disruption
- blood cell count
- blood chemistry study
- board certified oncology pharmacy specialist
- body image
- body mass index
- bolus dose
- bone density
- bone metastasis
- bone mineral density scan
- bone scan
- bone-seeking radioisotope
- brachytherapy
- brain metastasis
- BRCA1
- BRCA2
- BRCAPro
- breast carcinoma in situ
- breast-conserving surgery
- breast density
- breast duct
- breast duct endoscopy
- breast lobe
- breast lobule
- breast reconstruction
- breast self-exam
- Brief Pain Inventory
- cachexia
- CAF regimen
- calcification
- cancer vaccine
- candidiasis
- capecitabine
- carboplatin
- carcinogen
- carcinoma
- carcinoma in situ
- carcinomatous meningitis
- carcinosis
- carcinostatic
- cardiotoxicity
- caregiver
- carmustine
- case-control study
- case report
- case series
- CAT scan
- CBC
- cell
- cell-cycle regulation
- cell proliferation
- central nervous system
- central nervous system metastasis
- central nervous system prophylaxis
- central venous access catheter
- cetuximab
- cevimeline
- chaplain
- charged-particle radiation therapy
- chemoembolization
- chemoimmunotherapy
- chemoprevention
- chemoprevention study
- chemoprotective
- chemoradiation
- chemosensitivity
- chemosensitivity assay
- chemosensitizer
- chemotherapeutic agent
- chemotherapy
- chest wall
- chest X-ray
- Chinese meridian theory
- chronic
- chronic pain
- cisplatin
- Claus model
- clergy
- clinical
- clinical breast exam
- clinical practice guidelines
- clinical researcher
- clinical resistance
- clinical series
- clinical stage
- clinical staging
- clinical study
- clinical trial
- clinician
- clodronate
- CMF regimen
- cognition
- cognitive behavior therapy
- cognitive therapy
- cohort
- cohort study
- combination chemotherapy
- comedo carcinoma
- comfort care
- Coming Out
- Community Advisory Board
- comorbidity
- compassionate use trial
- complementary and alternative medicine
- complementary medicine
- complete metastasectomy
- complete remission
- complete response
- complex decongestive therapy
- compliance
- complication
- compression garment
- computed tomography scan
- concomitant
- concurrent therapy
- condition
- consolidation therapy
- constitutional acupuncture
- continuum of care
- contract research organization
- contraindication
- contralateral
- contrast material
- control group
- controlled clinical trial
- controlled study
- conventional medicine
- conventional therapy
- cope
- coping skills
- core biopsy
- core needle biopsy
- corticosteroid
- counseling
- COX inhibitor
- cryoablation
- cryopreservation
- cryosurgery
- CT scan
- cultural competency
- cumulative dose
- cumulative exposure
- cure
- cutaneous
- cutaneous breast cancer
- cyclophosphamide
- cyclosporine
- CYP2D6 inhibitor
- cystosarcoma phyllodes
- cytopenia
- cytotoxic
- cytotoxic chemotherapy
- Cytoxan
- Data and Safety Monitoring Board
- DCIS
- de novo
- debulking
- definitive surgery
- definitive treatment
- dehydration
- denosumab
- depression
- diagnosis
- diagnostic mammogram
- diagnostic procedure
- diagnostic technique
- diagnostic trial
- diameter
- diarrhea
- diaziquone
- DIEP flap
- dietary counseling
- dietary supplement
- dietitian
- differentiation
- diffuse
- digital mammography
- diphenhydramine
- discharge
- disease progression
- disease-specific survival rate
- distant cancer
- distant metastasis
- Distant recurrence
- distress
- DNR order
- docetaxel
- dolasetron
- dose
- dose-dense chemotherapy
- dose-dependent
- dose-limiting
- dose-rate
- double-blinded
- doxorubicin
- drain
- dronabinol
- droperidol
- drug interaction
- drug resistance
- drug therapy
- drug tolerance
- duct
- ductal carcinoma
- ductal carcinoma in situ
- ductal lavage
- duloxetine
- durable power of attorney
- dysfunction
- dysgeusia
- dyspepsia
- dyspnea
- early menopause
- early-stage breast cancer
- edema
- EEG biofeedback
- efficacy
- Eklund displacement views
- electroacupuncture
- electron beam
- eligibility criteria
- Ellence
- emesis
- emetic
- endocrine
- endocrine therapy
- endpoint
- energy healing
- enteral nutrition
- epidemiology
- epirubicin
- ER+
- ER-
- ER
- ER-PR-HER2/neu-
- eribulin mesylate
- erythema
- estradiol
- estrogen
- estrogen blocker
- estrogen receptor
- estrogen receptor-negative
- estrogen receptor-positive
- estrogen receptor test
- estrogen replacement therapy
- etanidazole
- etidronate
- everolimus
- Evista
- excision
- excisional biopsy
- exemestane
- expanded access trial
- experimental
- extranodal
- false-negative test result
- false-positive test result
- familial cancer
- family medical history
- Faslodex
- fast-neutron beam radiation
- fatigue
- FDA
- febrile neutropenia
- FEC regimen
- Femara
- fertility
- fexofenadine
- fibroadenoma
- fibrocystic breast changes
- fiducial marker
- film mammography
- fine-needle aspiration biopsy
- first-degree relative
- first-line therapy
- five-year survival rate
- fluorouracil
- fluoxetine
- FNA biopsy
- focal
- Food and Drug Administration
- Fosamax
- fractionation
- fulvestrant
- functional magnetic resonance imaging
- gadolinium
- Gail model
- gallium scan
- gamma irradiation
- Gamma Knife therapy
- gamma ray
- Gelclair
- gemcitabine
- gene
- gene expression profile
- gene therapy
- general anesthesia
- generalized anxiety disorder
- generic
- genetic
- genetic counseling
- genetic marker
- genetic marker of susceptibility
- genetic predisposition
- genetic profile
- genetic susceptibility
- genetic testing
- genetic testing
- genetics
- genome
- genome-wide association study
- genomic profile
- genomic test
- genomics
- gland
- Good Clinical Practice
- goserelin
- grade
- grading
- granisetron
- gross description
- Halaven
- hazard ratio
- healing touch
- Health Insurance Portability and Accountability Act
- healthcare provider
- healthcare proxy
- healthy control
- helical computed tomography
- HER2/neu
- Herceptin
- hereditary
- hereditary mutation
- heteronormative
- high-dose chemotherapy
- high-dose radiation
- high-energy proton therapy
- high grade
- high-risk cancer
- HIPPA
- histologic examination
- histology
- historic cohort study
- historical control subject
- homeopathic medicine
- hormonal therapy
- hormone
- hormone receptor
- hormone receptor test
- hormone replacement therapy
- hormone responsive
- hormone therapy
- hospice
- hot flash
- human epidermal growth factor receptor 2
- human participant protection regulations
- hydroxydaunorubicin
- hyperalimentation
- hypercalcemia
- hyperfractionated radiation therapy
- hyperfractionation
- hyperplasia
- hypersensitivity
- hypofractionated radiation therapy
- hypofractionation
- hypoxia
- ibandronate
- ibuprofen
- idiopathic
- image-guided radiation therapy
- imaging
- imaging procedure
- immune adjuvant
- immune function
- immune response
- immune system
- immune system tolerance
- immunization
- immunoassay
- immunocompromised
- immunodeficiency
- immunohistochemistry
- immunology
- immunomodulation
- immunosuppression
- immunotherapy
- implant
- implant displacement views
- implant radiation therapy
- implantable pump
- in situ
- incidence
- incision
- incisional biopsy
- indication
- indolent
- induction therapy
- infection
- infertile
- infertility
- infiltrating breast cancer
- infiltrating ductal carcinoma
- inflammation
- inflammatory breast cancer
- informed consent
- infusion
- ingestion
- inherited
- iniparib
- injection
- inoperable
- insomnia
- Institutional Review Board
- intensification therapy
- intensity-modulated radiation therapy
- interfering thought
- internal mammary lymph nodes
- internal radiation therapy
- International Unit
- internist
- interstitial radiation therapy
- intervention
- intervention group
- intra-arterial
- intracarotid infusion
- intradermal
- intraductal breast papilloma
- intraductal carcinoma
- intrahepatic
- intrahepatic infusion
- intramuscular
- intramuscular injection
- intraoperative radiation therapy
- intraoperative ultrasound
- intratumoral
- intravasation
- intravenous
- intravenous infusion
- intravenous injection
- intrusive thought
- intrusive thoughts
- invasive breast cancer
- invasive cancer
- invasive procedure
- investigational
- investigator
- ionizing radiation
- ipsilateral
- IRB
- irradiated
- irradiation
- irreversible toxicity
- ixabepilone
- joint pain
- Karnofsky Performance Status
- laboratory test
- lapatinib
- laser
- laser surgery
- laser therapy
- lassitude
- late effects
- late-stage cancer
- latent
- laxative
- LEEP
- legal aid organization
- lesion
- lethargy
- letrozole
- leukopenia
- levels of evidence
- Lexapro
- libido
- lidocaine
- ligation
- linac
- linear accelerator
- lipoma
- lisofylline
- liver metastasis
- liver scan
- living will
- lobaplatin
- lobe
- lobectomy
- lobular carcinoma
- lobular carcinoma in situ
- lobule
- local anesthesia
- local cancer
- local therapy
- localization
- localized
- locally advanced cancer
- locally recurrent cancer
- lomustine
- loop electrosurgical excision procedure
- loop excision
- lorazepam
- low grade
- lubricant
- lumbar puncture
- lumpectomy
- lung metastasis
- luteinizing hormone-releasing hormone agonist
- lymph
- lymph gland
- lymph node
- lymph node dissection
- lymph node drainage
- lymph node mapping
- lymph vessel
- lymphadenectomy
- lymphadenopathy
- lymphangiogram
- lymphangiography
- lymphatic basin
- lymphatic fluid
- lymphatic mapping
- lymphatic system
- lymphatic vessel
- lymphedema
- lymphography
- lymphoscintigraphy
- Lyrica
- lytic lesion
- macrocalcification
- magnetic resonance imaging
- magnetic resonance perfusion imaging
- magnetic resonance spectroscopic imaging
- mainstream medicine
- maintenance therapy
- male breast cancer
- malignancy
- malignant
- malignant pleural effusion
- malnutrition
- mammary
- mammary dysplasia
- mammary gland
- mammogram
- mammography
- MammoSite
- Mammotome
- mantle field
- MAO inhibitor
- margin
- marker
- mass
- massage therapy
- mastectomy
- mastitis
- maternal
- maximum tolerated dose
- mean survival time
- measurable disease
- medial supraclavicular lymph node
- median
- median survival time
- Medicaid
- medical castration
- medical device
- medical nutrition therapy
- medical oncologist
- Medicare
- medicine
- medullary breast carcinoma
- mega-voltage linear accelerator
- megestrol
- melphalan
- meningeal metastasis
- menopause
- menorrhagia
- menstrual cycle
- menstrual period
- menstruation
- mental health
- mental health counselor
- meridian
- mesna
- meta-analysis
- metallic
- metastasectomy
- metastasis
- metastasize
- metastatic
- methotrexate
- metoclopramide
- metronomic therapy
- microcalcification
- micrometastasis
- microscopic
- milk duct
- mind/body exercise
- mindfulness relaxation
- Miraluma test
- mitigate
- modified radical mastectomy
- molecular marker
- molecular medicine
- molecular risk assessment
- molecularly targeted therapy
- monoamine oxidase inhibitor
- monoclonal antibody
- morbidity
- mortality
- MRI
- MRSI
- MTD
- mTOR
- mucositis
- multicenter study
- multicentric breast cancer
- multidisciplinary
- multidisciplinary opinion
- multidrug resistance
- multidrug resistance inhibition
- multifocal breast cancer
- music therapy
- mutation
- mutation carrier
- myalgia
- myelosuppression
- nanoparticle paclitaxel
- narcotic
- National Cancer Institute
- National Center for Complementary and Alternative Medicine
- National Institutes of Health
- natural history study
- naturopathy
- nausea
- NCCAM
- NCI
- NCI clinical trials cooperative group
- needle biopsy
- needle localization
- needle-localized biopsy
- negative axillary lymph node
- negative test result
- neoadjuvant therapy
- neoplasm
- nerve
- nerve block
- neurocognitive
- neurologic
- neuropathy
- neurotoxicity
- neurotoxin
- neutropenia
- NIH
- nipple
- nipple discharge
- nitrosourea
- NMRI
- node-negative
- node-positive
- nodule
- nonblinded
- nonconsecutive case series
- noninvasive
- nonmalignant
- nonmetastatic
- nonprescription
- nonrandomized clinical trial
- nonsteroidal anti-inflammatory drug
- nonsteroidal aromatase inhibitor
- nontoxic
- normal range
- normative
- NP
- NPO
- NSAID
- nuclear grade
- nuclear magnetic resonance imaging
- nuclear medicine scan
- nurse
- nurse practitioner
- nutrition
- nutrition therapy
- nutritional counseling
- nutritional status
- nutritional supplement
- nutritionist
- obese
- objective improvement
- objective response
- observation
- observational study
- obstruction
- off-label
- olaparib
- oncologist
- oncology
- oncology nurse
- oncology pharmacy specialist
- oncolysis
- ondansetron
- onset of action
- oophorectomy
- open biopsy
- open label study
- open resection
- operable
- opiate
- opioid
- opportunistic infection
- oral
- organ
- orthodox medicine
- osteolytic
- osteonecrosis of the jaw
- osteopenia
- osteoporosis
- OTC
- outcome
- outpatient
- ovarian
- ovarian ablation
- ovarian cancer
- ovarian suppression
- ovary
- over-the-counter
- overall survival rate
- overdose
- overexpress
- overweight
- ovulation
- PA
- paclitaxel
- paclitaxel albumin-stabilized nanoparticle formulation
- paclitaxel-loaded polymeric micelle
- Paget disease of the nipple
- pain threshold
- palliation
- palliative care
- palliative therapy
- palmar-plantar erythrodysesthesia
- palonosetron hydrochloride
- palpable disease
- palpation
- palpitation
- pamidronate
- panic
- papillary tumor
- Paraplatin
- parenteral nutrition
- paroxetine hydrochloride
- PARP
- PARP inhibitor
- partial-breast irradiation
- partial mastectomy
- partial oophorectomy
- partial remission or partial response
- pastoral counselor
- paternal
- pathologic fracture
- pathological stage
- pathological staging
- pathologist
- pathology report
- patient advocate
- Paxil
- peau d'orange
- pedigree
- peer-review process
- peer-reviewed scientific journal
- perfusion magnetic resonance imaging
- perimenopausal
- periodic neutropenia
- perioperative
- peripheral neuropathy
- peripheral venous catheter
- personal health record
- personal medical history
- personalized medicine
- Pertuzumab
- PET scan
- pharmacist
- phase I/II trial
- phase I trial
- phase II/III trial
- phase II trial
- phase III trial
- phase IV trial
- phlebotomy
- photon beam radiation therapy
- phyllodes tumor
- physical examination
- physical therapist
- physical therapy
- physician
- physician assistant
- physiologic
- PI3 kinase inhibitor
- pilocarpine
- pilot study
- placebo
- placebo-controlled
- plastic surgeon
- plastic surgery
- population study
- positive axillary lymph node
- positive test result
- positron emission tomography scan
- post-traumatic stress disorder
- postmenopausal
- postoperative
- postremission therapy
- potentiation
- power of attorney
- PR
- PR+
- PR-
- practitioner
- precancerous
- preclinical study
- predictive factor
- pregabalin
- premalignant
- premature menopause
- premenopausal
- prescription
- prevention
- preventive
- preventive mastectomy
- primary care
- primary care doctor
- primary endpoint
- primary therapy
- primary treatment
- primary tumor
- Principal investigator
- prochlorperazine
- progesterone
- progesterone receptor
- progesterone receptor-negative
- progesterone receptor-positive
- progesterone receptor test
- progestin
- prognosis
- prognostic factor
- progression
- progression-free survival
- progressive disease
- Prolia
- proliferative index
- promegapoietin
- prophylactic
- prophylactic mastectomy
- prophylactic oophorectomy
- prophylactic surgery
- prophylaxis
- prospective
- prospective cohort study
- prosthesis
- protective factor
- protein
- protein-bound paclitaxel
- protein expression
- protein expression profile
- protocol
- proton
- proton magnetic resonance spectroscopic imaging
- pruritus
- psychiatrist
- psychological
- psychologist
- psychosocial
- psychotherapy
- PTSD
- pump
- punch biopsy
- qi
- qigong
- quadrantectomy
- quality assurance
- quality of life
- radiation
- radiation brachytherapy
- radiation dermatitis
- radiation fibrosis
- radiation necrosis
- radiation nurse
- radiation oncologist
- radiation physicist
- radiation surgery
- radiation therapist
- radiation therapy
- radical lymph node dissection
- radical mastectomy
- radioactive
- radioactive drug
- radioactive seed
- radioisotope
- radiologic exam
- radiologist
- radiology
- radionuclide
- radionuclide scanning
- radiopharmaceutical
- radiosensitization
- radiosensitizer
- radiosurgery
- radiotherapy
- raloxifene
- raloxifene hydrochloride
- randomization
- randomized clinical trial
- receptor
- RECIST
- reconstructive surgeon
- reconstructive surgery
- recreational therapy
- recurrence
- recurrent cancer
- referral
- reflexology
- refractory
- refractory cancer
- regimen
- regional
- regional anesthesia
- regional cancer
- regional chemotherapy
- regional lymph node
- regional lymph node dissection
- registered dietician
- regression
- rehabilitation
- rehabilitation specialist
- relapse
- relative survival rate
- relaxation technique
- remission
- remission induction therapy
- remote brachytherapy
- research nurse
- research study
- resectable
- resected
- resection
- residual disease
- resistant cancer
- resorption
- respite care
- response rate
- retrospective cohort study
- retrospective study
- risk factor
- Rubex
- salpingo-oophorectomy
- salvage therapy
- samarium 153
- sargramostim
- scalpel
- scan
- scanner
- scintigraphy
- scintimammography
- sclerosing adenosis
- screening
- screening mammogram
- second-line therapy
- second-look surgery
- second primary cancer
- secondary cancer
- secrete
- sedative
- segmental mastectomy
- selection bias
- selective estrogen receptor modulator
- selective serotonin reuptake inhibitor
- sentinel lymph node
- sentinel lymph node biopsy
- sentinel lymph node mapping
- sepsis
- sequential AC/Taxol-Trastuzumab regimen
- sequential treatment
- SERM
- sertraline
- Serzone
- sestamibi breast imaging
- sexuality
- sibling
- side effect
- silicone
- simple mastectomy
- simulation
- Single-agent therapy
- sleep disorder
- social service
- social support
- social worker
- sodium thiosulfate
- soft tissue
- solid tumor
- somatic
- somatic mutation
- sorafenib
- specialist
- specificity
- spiculated mass
- spinal anesthesia
- spinal block
- spiral CT scan
- spirituality
- sporadic cancer
- SSRI
- stable disease
- stage
- stage 0 breast carcinoma in situ
- stage 0 disease
- stage I breast cancer
- stage IA breast cancer
- stage IB breast cancer
- stage II breast cancer
- stage II breast cancer
- stage IIA breast cancer
- stage IIB breast cancer
- stage III breast cancer
- stage III lymphedema
- stage IIIA breast cancer
- stage IIIB breast cancer
- stage IIIC breast cancer
- stage IV breast cancer
- staging
- stamina
- standard of care
- standard therapy
- statistically significant
- stent
- stereotactic biopsy
- stereotactic radiosurgery
- sterile
- sternum
- steroid
- stress
- strontium
- study agent
- subcutaneous
- subcutaneous port
- subjective improvement
- subset analysis
- supplemental nutrition
- supplementation
- support group
- supportive care
- supraclavicular lymph node
- surgeon
- surgery
- surgical biopsy
- surgical menopause
- surgical oncologist
- survival rate
- symptom
- symptom management
- symptomatic
- synergistic
- synthetic
- syringe
- systemic
- systemic chemotherapy
- systemic disease
- systemic therapy
- TAC regimen
- tai chi
- tailored intervention
- talk therapy
- tamoxifen
- targeted therapy
- taxane
- Taxol
- Taxotere
- Tc 99m sulfur colloid
- technician
- terminal disease
- therapeutic
- therapeutic touch
- therapy
- thermography
- thiethylperazine
- thiotepa
- third-line therapy
- thrush
- time to progression
- tinnitus
- tissue
- tissue flap reconstruction
- TNM staging system
- tomography
- tomotherapy
- topical
- topical chemotherapy
- topoisomerase inhibitor
- total estrogen blockade
- total mastectomy
- total nodal irradiation
- total parenteral nutrition
- toxic
- toxicity
- tracer
- traditional acupuncture
- tranquilizer
- transdermal
- transfusion
- transitional care
- translational research
- trastuzumab
- trauma
- treatment field
- trigger
- trigger point acupuncture
- triple-negative breast cancer
- tumescent mastectomy
- tumor
- tumor antigen vaccine
- tumor board review
- tumor burden
- tumor debulking
- tumor load
- tumor marker
- tumor volume
- Tykerb
- ulcer
- ulceration
- ultrasound-guided biopsy
- ultrasound/ultrasonography
- ultraviolet radiation therapy
- uncontrolled study
- undifferentiated
- unilateral
- unilateral salpingo-oophorectomy
- unresectable
- unresected
- upstaging
- urticaria
- VACB
- vaccine therapy
- vacuum-assisted biopsy or vacuum-assisted core biopsy
- Valium
- vancomycin
- vandetanib
- vascular endothelial growth factor-antisense oligonucleotide
- vascular endothelial growth factor receptor tyrosine kinase inhibitor
- vein
- Velban
- venipuncture
- venous sampling
- Versed
- vertebroplasty
- vinorelbine
- vital
- vomit
- watchful waiting
- wedge resection
- Wellcovorin
- Western medicine
- WGA study
- white blood cell
- whole cell vaccine
- whole genome association study
- wide local excision
- wire localization
- wound
- X-ray therapy
- Xanax
- Xeloda
- xerostomia
- Xgeva
- yoga
- ziconotide
- Zinecard
- Zofran
- zoledronic acid
- Zoloft
- Zometa
Living Beyond Breast Cancer is a national nonprofit organization that seeks to create a world that understands there is more than one way to have breast cancer. To fulfill its mission of providing trusted information and a community of support to those impacted by the disease, Living Beyond Breast Cancer offers on-demand emotional, practical, and evidence-based content. For over 30 years, the organization has remained committed to creating a culture of acceptance — where sharing the diversity of the lived experience of breast cancer fosters self-advocacy and hope. For more information, learn more about our programs and services.